The Israel Cancer Association lauds the decisions of the 2013 Health Basket Committee


Big-Bullet-SQR.gif The ICA commends the decisions of the Medications Basket Committee and lauds the inclusion of new and important medications in the health basket, including essential drugs for cancer therapy.


Big-Bullet-SQR.gif Increasing the number of drugs and technologies to be included in this year's public health insurance scheme will enable a larger number of patients to receive potentially life-saving treatment.


Big-Bullet-SQR.gif However, ICA is disconcerted by the fact that some of the medications have been excluded from the basket, and calls upon the Prime Minister and Finance Minister, as it has many times in the past, to establish an annual automatic update of the health basket by 2%, which will facilitate a long-term solution through state budget allocation, and will alleviate patient's suffering.


Big-Bullet-SQR.gif Main drugs for cancer patients now included 2013 health basket:


bul3 Femara Arimidex Aromasin Afinitor Perjeta for breast cancer
bul3 Avastin for ovarian cancer, fallopian tube carcinoma and pritoneal cancer
bul3 Zytiga for prostate cancer
bul3 Caprelsa for thyroid cancer
bul3 Votrient for soft tissue sarcomas
bul3 Erivedge for BCC (basal-cell carcinoma) skin cancer
bul3 Sprycel, Difolta, Istodax for hematological malignancies


Big-Bullet-SQR.gif Drug approved for cancer prevention:

bul3 Gardasil, a vaccine against HPV (human papilloma virus) to prevent cervical cancer

Big-Bullet-SQR.gif Likewise, the following drugs were approved:

bul3 Expansion of eligibility for dental care for cancer patients receiving head and neck radiation therapy
bul3 FDG PET/CT Imaging - diffuse myeloma and detection of cancer from an unknown source 
bul3 Eporatio for the treatment of anemia in cancer patients receiving chemotherapy